AbbVie | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Abbott USD 4.21B 7.48B 2025-03
ALKERMES USD 45.63M 8.59M 2024-12
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.54B 79M 2025-03
Biogen USD 424.2M 1.5M 2024-12
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Eisai JPY 64.53B 1.79B 2024-12
Eli Lilly USD 3.44B 213.4M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
J&J USD 9.54B 766M 2025-03
Medtronic USD 2.29B 90M 2025-01
Merck USD 4.08B 493M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Pacira USD 19.13M 234K 2024-12
Perrigo USD 495.2M 36.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
UCB 750M 1.66B 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
United Therapeutics 6M 357.9M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Zoetis USD 433M 29M 2024-12



AbbVie Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.